Trials / Completed
CompletedNCT02127788
Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematology
Observational, Longitudinal, Prospective, French, Multicentre Study Conducted on Adult and Paediatric Patients Treated With Micafungin in Prophylaxis and Followed Over a 3 Months' Period in Routine Medical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Astellas Pharma S.A.S. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this observational study is to describe the actual conditions of prescription of micafungin in antifungal prophylaxis in French haematological and onco-haematological units. The efficacy and the safety outcomes will be described.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Micafungin | intravenous |
Timeline
- Start date
- 2014-07-03
- Primary completion
- 2016-01-27
- Completion
- 2016-01-27
- First posted
- 2014-05-01
- Last updated
- 2024-10-21
Locations
17 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02127788. Inclusion in this directory is not an endorsement.